Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis

被引:49
|
作者
Pierrot-Deseilligny, Charles [1 ]
Souberbielle, Jean-Claude [2 ]
机构
[1] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Serv Neurol 1, Paris, France
[2] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct, Paris, France
关键词
Epstein-Barr virus; genetics; multiple sclerosis; smoking; vitamin D; EPSTEIN-BARR-VIRUS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SERUM 25-HYDROXYVITAMIN D; BONE-MINERAL DENSITY; ENVIRONMENTAL RISK-FACTORS; CENTRAL-NERVOUS-SYSTEM; PLACEBO-CONTROLLED TRIAL; REGULATORY T-CELLS; D-RECEPTOR GENE; 1,25-DIHYDROXYVITAMIN D-3;
D O I
10.1177/1756285612473513
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis (MS) is reviewed. Among the multiple recently discovered actions of vitamin D, an immunomodulatory role has been documented in experimental autoimmune encephalomyelitis and in humans. This action in the peripheral immune system is currently the main known mechanism through which vitamin D might influence MS, but other types of actions could be involved within the central nervous system. Furthermore, vitamin D insufficiency is widespread in temperate countries and in patients with MS at the earliest stages of the disease, suggesting that the deleterious effects related to vitamin D insufficiency may be exerted in these patients. In fact, many genetic and environmental risk factors appear to interact and contribute to MS. In genetics, several human leukocyte antigen (HLA) alleles (more particularly HLA-DRB1*1501) could favour the disease whereas some others could be protective. Some of the genes involved in vitamin D metabolism (e.g. CYP27B1) also play a significant role. Furthermore, three environmental risk factors have been identified: past Epstein-Barr virus infection, vitamin D insufficiency and cigarette smoking. Interactions between genetic and environmental risk or protective factors may occur during the mother's pregnancy and could continue during childhood and adolescence and until the disease is triggered in adulthood, therefore possibly modulating the MS risk throughout the first decades of life. Furthermore, some clinical findings already strongly suggest that vitamin D status influences the relapse rate and radiological lesions in patients with MS, although the results of adequately powered randomized clinical trials using vitamin D supplementation have not yet been reported. While awaiting these incontrovertible results, which might be long in coming, patients with MS who are currently in vitamin D insufficiency should be supplemented, at least for their general health status, using moderate doses of the vitamin.
引用
收藏
页码:81 / 116
页数:36
相关论文
共 50 条
  • [41] Vitamin D and multiple sclerosis
    Raghuwanshi, Anita
    Joshi, Sneha S.
    Christakes, Sylvia
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 105 (02) : 338 - 343
  • [42] Vitamin D and multiple sclerosis
    Harandi, Asghar Amini
    Harandi, Ali Amini
    Pakdaman, Hossein
    Sahraian, Mohammad Ali
    IRANIAN JOURNAL OF NEUROLOGY, 2014, 13 (01) : 1 - 6
  • [43] Vitamin D and multiple sclerosis
    Ascherio, Alberto
    Munger, Kassandra L.
    Simon, K. Claire
    LANCET NEUROLOGY, 2010, 9 (06) : 599 - 612
  • [44] Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
    Liu, Rongzeng
    Du, Shushu
    Zhao, Lili
    Jain, Sahil
    Sahay, Kritika
    Rizvanov, Albert
    Lezhnyova, Vera
    Khaibullin, Timur
    Martynova, Ekaterina
    Khaiboullina, Svetlana
    Baranwal, Manoj
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis
    Mowry, Ellen M.
    James, Judith A.
    Krupp, Lauren B.
    Waubant, Emmanuelle
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (06) : 666 - 671
  • [46] Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism
    Kocovska, Eva
    Gaughran, Fiona
    Krivoy, Amir
    Meier, Ute-Christiane
    FRONTIERS IN PSYCHIATRY, 2017, 8
  • [47] Vitamin D: Evidence for its role as a prognostic factor in multiple sclerosis
    Mowry, Ellen M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 311 (1-2) : 19 - 22
  • [48] Role of Viruses in the Pathogenesis of Multiple Sclerosis
    Tarlinton, Rachael E.
    Martynova, Ekaterina
    Rizvanov, Albert A.
    Khaiboullina, Svetlana
    Verma, Subhash
    VIRUSES-BASEL, 2020, 12 (06):
  • [49] EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature
    Nejati, Ahmad
    Shoja, Zabihollah
    Shahmahmoodi, Shohreh
    Tafakhori, Abbas
    Mollaei-Kandelous, Yaghoub
    Rezaei, Farhad
    Hamid, Kabir Magaji
    Mirshafiey, Abbas
    Doosti, Rozita
    Sahraian, Mohammad Ali
    Mahmoudi, Mahmood
    Shokri, Fazel
    Emery, Vince
    Marashi, Sayed Mahdi
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2016, 205 (02) : 143 - 154
  • [50] The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update
    Sangha, Amarpreet
    Quon, Michaela
    Pfeffer, Gerald
    Orton, Sarah-Michelle
    NUTRIENTS, 2023, 15 (13)